Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics
Dementia affects about 47 million people worldwide, number expected to exponentially increase within 30 years. Alzheimer’s disease (AD) is the most common dementia type, accounting on its own for almost 70% of all dementia cases. Behavioral and psychological symptoms (BPSD) frequently occur during t...
Main Authors: | Valeria Calsolaro, Grazia Daniela Femminella, Sara Rogani, Salvatore Esposito, Riccardo Franchi, Chukwuma Okoye, Giuseppe Rengo, Fabio Monzani |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/3/246 |
Similar Items
-
Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects
by: Yukihiro Ohno, et al.
Published: (2019-09-01) -
A single blind comparative clinical study of the effects of chlorpromazine and risperidone on positive and negative symptoms in patients of schizophrenia
by: Amrita Prakash Singam, et al.
Published: (2011-01-01) -
Eficácia e segurança dos antipsicóticos atípicos nas demências: uma revisão sistemática Efficacy and safety of atypical antipsychotics in dementia: a sistematic review
by: Melissa Guarieiro Ramos, et al.
Published: (2006-01-01) -
EFFECT OF TYPICAL AND ATYPICAL ANTIPSYCHOTICS ON PLASMA PROLACTIN LEVELS IN SCHIZOPHRENIA
by: Muhammad Sami Bilal, et al.
Published: (2015-01-01) -
Quality Improvement Project: Reduction of Antipsychotic Use in Nursing Home Patients with Dementia
by: Moroz, Marina, et al.
Published: (2013)